tiprankstipranks
XTL Biopharmaceuticals Ltd. Sponsored ADR (XTLB)
NASDAQ:XTLB
US Market
XTLB
XTL Biopharmaceuticals Sponsored ADR
RESEARCH TOOLSreports

XTL Biopharmaceuticals Sponsored ADR (XTLB) Income Statement

134 Followers

XTL Biopharmaceuticals Sponsored ADR Income Statement

Last quarter (Q4 2024), XTL Biopharmaceuticals Sponsored ADR's total revenue was $289.00K, an increase of Infinity% from the same quarter last year. In Q4, XTL Biopharmaceuticals Sponsored ADR's net income was $-255.00K. See XTL Biopharmaceuticals Sponsored ADR’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
$ 451.00K$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit
$ 3.00K$ 0.00$ -1.00K$ -1.00K$ -1.00K
Operating Expenses
$ 2.17M$ 765.00K$ 880.00K$ 1.03M$ 948.00K
Depreciation and Amortization
$ 199.00K$ 1.00K$ 1.00K$ 1.00K$ 1.00K
EBITDA
$ -930.00K$ -764.00K$ -879.00K$ -1.03M$ -947.00K
Operating Income
$ -2.17M$ -765.00K$ -880.00K$ -1.03M$ -948.00K
Other Income/Expenses
$ 1.01M$ -1.02M$ -468.00K$ 1.47M$ -2.01M
Pretax Income
$ -1.16M$ -1.78M$ -1.35M$ 435.00K$ -2.95M
Net Income
$ -1.03M$ -1.78K$ -1.35M$ 435.00K$ -782.00K
Per Share Metrics
Basic EPS
$ -2.40$ 0.00$ -4.00$ 1.28$ -9.12
Diluted EPS
$ -2.40$ 0.00$ -4.00$ 1.12$ -9.12
Weighted Average Shares Outstanding
 420.65K 340.60K 340.68K 332.50K 321.38K
Weighted Average Shares Outstanding (Diluted)
 440.10K 340.57K 340.57K 384.72K 321.38K
Currency in USD

XTL Biopharmaceuticals Sponsored ADR Earnings and Revenue History